JAM
Jupiter Asset Management’s Edwards Lifesciences EW Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-256,347
| Closed | -$23.7M | – | 430 |
|
2024
Q2 | $23.7M | Buy |
256,347
+253,437
| +8,709% | +$23.4M | 0.22% | 142 |
|
2024
Q1 | $278K | Sell |
2,910
-427,300
| -99% | -$40.8M | ﹤0.01% | 407 |
|
2023
Q4 | $32.8M | Sell |
430,210
-372,036
| -46% | -$28.4M | 0.33% | 94 |
|
2023
Q3 | $55.6M | Buy |
802,246
+661,374
| +469% | +$45.8M | 0.62% | 36 |
|
2023
Q2 | $13.3M | Sell |
140,872
-16,855
| -11% | -$1.59M | 0.15% | 181 |
|
2023
Q1 | $13M | Sell |
157,727
-511,464
| -76% | -$42.3M | 0.18% | 160 |
|
2022
Q4 | $49.9M | Buy |
669,191
+28,938
| +5% | +$2.16M | 0.73% | 27 |
|
2022
Q3 | $52.9M | Sell |
640,253
-3,539
| -0.5% | -$292K | 0.82% | 25 |
|
2022
Q2 | $61.3M | Buy |
643,792
+22,846
| +4% | +$2.17M | 0.86% | 17 |
|
2022
Q1 | $73.1M | Buy |
620,946
+132,841
| +27% | +$15.6M | 0.87% | 18 |
|
2021
Q4 | $63.8M | Buy |
488,105
+4,774
| +1% | +$624K | 0.7% | 26 |
|
2021
Q3 | $54.7M | Buy |
483,331
+44,934
| +10% | +$5.09M | 0.62% | 35 |
|
2021
Q2 | $45.4M | Sell |
438,397
-126,763
| -22% | -$13.1M | 0.47% | 56 |
|
2021
Q1 | $47.3M | Sell |
565,160
-294,117
| -34% | -$24.6M | 0.46% | 57 |
|
2020
Q4 | $78.4M | Sell |
859,277
-114,936
| -12% | -$10.5M | 0.79% | 19 |
|
2020
Q3 | $77.7M | Buy |
974,213
+969,077
| +18,868% | +$77.3M | 0.82% | 21 |
|
2020
Q2 | $355K | Buy |
+5,136
| New | +$355K | 0.01% | 254 |
|